Emerging Stocks Down Under 30 November 2021: Nearmap, Clarity Pharmaceuticals, Pacific Edge

Emerging Stocks Down Under 30 11 21

Nearmap: Medium term upside in a downtrend

In today's edition of Emerging Stocks Down Under, aerial imaging company Nearmap has been on a longer term downtrend. But we believe there may be upside to $1.90-2.00 within that downtrend in the near to medium term.   Also in today's edition, radiopharmaceutical company Clarity Pharmaceuticals (ASX: CU6) and cancer diagnostics company Pacific Edge (ASX: PEP).  

Click here to read the previous edition of Emerging Stocks Down Under published 23 November 2021

For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter.

Please register or upgrade your plan to access this content.

Save $$$
30-Day Free Trial
$0
No Credit Card Required!
Get access to 5 publications per week
Weekly Investor Webinar
Profit Premium
$69
Get access to 5 publications per week
Access to the full research Archive
Weekly Investor Webinar
30-Day Free Trial
$0
No Credit Card Required!
Get access to 5 publications per week
Weekly Investor Webinar
Profit Premium
$59
BILLED ANNUALLY
Get access to 5 publications per week
Access to the full research Archive
Weekly Investor Webinar